The only solution in the absence of real human models is to create computerised "in-silico" models that simulate the real heart and enable possible drugs and therapies to be tested without risk to people. Although this is still some way off becoming a reality, substantial progress has been made, and the next steps were plotted at a major workshop held recently by the European Science Foundation (ESF).
The workshop highlighted how recent progress in imaging technologies was helping heart modellers overcome the big dilemma they have faced up till now - actually proving that the models really are an accurate representation of the real human heart. This has been the big "catch 22" of heart modelling, that in order to create a realistic model, you need accurate and extensive data from real hearts for calibration.
"Validation of the models is very important, and was raised at the workshop," said Blanca Rodriguez, scientific coordinator of the ESF workshop, and senior cardiac researcher at Oxford University, Europe's leading centre for cardiac modelling. "One of the problems has been that it is much easier to get experimental data from animals than humans."
Such animal data can help calibrate some aspects of the models, but only data from human hearts can fine tune them to the point at which they can actually make useful predictions and test therapies. Fortunately such data is now becoming available as a result of dramatic progress in imaging techniques that can observe cardiac activity externally without need for invasive probes. "We are now getting data at very high resolutions, and that allows us to model things in more detail, with greatly improved anatomy and structure," said Rodriguez. This in turn requires access to greater computational power and more sophisticated software, both of which are available at Oxford.
The models in turn are allowing researchers to study disease and understand what can go wrong, which is the first step towards developing cures. One of the most important diseases being modelled is myocardial ischaemia, which is the loss of blood supply to part of the heart muscle, leading ultimately to failure and potentially death if untreated.
Typically victims of heart failure never fully recover their former health and vigour, because part of the heart muscle has been permanently lost. However stem cell therapy holds the promise of being able to regenerate heart muscle destroyed by disease, but this will require careful testing to eliminate possibly dangerous side effects, such as cancer and disruption of normal heart rhythms, leading to arrhythmia, or irregular heart beats. Here again the heart models could play a vital role. "They could be used to model stem cells' behaviour, and see how they are incorporated into the heart," said Rodriguez.
The ESF workshop also had another dimension - to kick start a Europe-wide effort to catch up with the US in this vital field. Oxford was once the world leader, for remarkably the first cardiac model was developed almost half a century ago in 1961 by Dennis Noble, who although now officially retired is still assisting Rodriguez and colleagues today. Noble's original model was of just of a single heart cell. But since the late 1990s, the models have been extended to the whole organ, incorporating multiple cell types.
The workshop identified three key issues that had to be addressed, according to Rodriguez. The first one was to improve the links within Europe's scattered heart modelling community. The second two recommendations, less specific to Europe, were to create a standard and robust software infrastructure for sharing heart models and associated data, and to define exactly how to calibrate the models more effectively from experimental data.
The next step is to act on these recommendations, but Rodriguez is now confident that Europe is well placed to regain its early momentum in this vital field of medical research.
The ESF Exploratory Workshop on European Heart Modelling and Supporting Technology was held in Oxford, United Kingdom, in May 2007. The Exploratory Workshop titled Exploring Symbolic Value Creation In Organizations was held on 6-9 September 2007 in Milano, Italy. Each year, ESF supports approximately 50 Exploratory Workshops across all scientific domains. These small, interactive group sessions are aimed at opening up new directions in research to explore new fields with a potential impact on developments in science.
Thomas Lau | alfa
NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University
How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine